Novo Nordisk A/S ADR (NVO)
62.60 x 100 63.26 x 100
Post-market by (Cboe BZX)
62.62 +0.54 (+0.87%) 04/28/25 [NYSE]
62.60 x 100 63.26 x 100
Post-market 62.72 +0.10 (+0.16%) 19:59 ET
for Mon, Apr 28th, 2025
Results
download Want to compare other data? Select Fields| Symbol | NVO | ABBV | NVS | ||
| Company | Novo Nordisk A/S ADR | Abbvie Inc | Novartis Ag ADR | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 62.19 | 188.00 | 112.33 | ||
| High | 63.25 | 193.12 | 113.44 | ||
| Low | 61.97 | 187.64 | 112.17 | ||
| Last | 62.62 | 192.34 | 112.63 | ||
| Change | +0.54 | +6.28 | +0.49 | ||
| % Change | +0.87% | +3.38% | +0.44% | ||
| Volume | 6,280,300 | 10,408,000 | 2,477,000 | ||
| 20-Day Average Volume | 10,306,450 | 10,022,859 | 2,588,845 | ||
| Previous Close | 62.08 | 186.06 | 112.14 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 63.50 | 184.06 | 108.87 | ||
| 20-Day Raw Stochastic | 43.23% | 58.52% | 89.18% | ||
| 20-Day Relative Strength | 39.88% | 52.15% | 56.71% | ||
| Weighted Alpha | -55.23 | +14.31 | +13.91 | ||
| Today's Opinion | 100% Sell | 8% Buy | 48% Buy | ||
| Previous Opinion | 100% Sell | 24% Sell | 48% Buy | ||
| Last Month's Opinion | 100% Sell | 80% Buy | 40% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +7.35% since 04/21/25 | +13.03% since 04/21/25 | +1.89% since 04/21/25 | ||
| Low | 58.92 on 04/22/25 | 170.91 on 04/22/25 | 109.51 on 04/23/25 | ||
| High | 63.25 on 04/28/25 | 193.12 on 04/28/25 | 113.44 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -9.64% since 03/28/25 | -6.31% since 03/28/25 | +0.05% since 03/28/25 | ||
| Low | 57.00 on 04/21/25 | 164.39 on 04/09/25 | 97.71 on 04/09/25 | ||
| High | 70.00 on 04/01/25 | 212.15 on 04/01/25 | 114.44 on 04/03/25 | ||
| 3-Month | |||||
| %Chg | -26.49% since 01/28/25 | +10.03% since 01/28/25 | +10.60% since 01/28/25 | ||
| Low | 57.00 on 04/21/25 | 164.39 on 04/09/25 | 97.71 on 04/09/25 | ||
| High | 93.80 on 02/25/25 | 218.66 on 03/10/25 | 116.91 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | -44.27% since 10/28/24 | +1.40% since 10/28/24 | -2.59% since 10/28/24 | ||
| Low | 57.00 on 04/21/25 | 163.81 on 11/19/24 | 96.06 on 12/20/24 | ||
| High | 113.76 on 10/30/24 | 218.66 on 03/10/25 | 116.91 on 03/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 280,695,136 | 330,728,128 | 223,599,872 | ||
| Shares Outstanding, K | 4,487,532 | 1,768,978 | 2,112,422 | ||
| Annual Sales | 42,108,430,000 | 56,334,000,000 | 51,722,000,000 | ||
| Annual Net Income | 14,643,260,000 | 4,278,000,000 | 11,941,000,000 | ||
| Last Quarter Sales | 12,261,320,000 | 15,102,000,000 | 13,558,000,000 | ||
| Last Quarter Net Income | 4,026,620,000 | -22,000,000 | 2,818,000,000 | ||
| 60-Month Beta | 0.61 | 0.55 | 0.56 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 02/05/25 | 2.46 on 04/25/25 | 1.98 on 01/31/25 | ||
| Latest Earnings Date | 05/07/25 | 04/25/25 | 04/29/25 | ||
| Most Recent Dividend | 0.819 on 03/31/25 | 1.640 on 04/15/25 | 2.596 on 03/12/25 | ||
| Next Ex-Dividends Date | 03/31/25 | 04/15/25 | 03/12/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 18.87 | 18.12 | 14.36 | ||